Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management

DM Black, B Abrahamsen, ML Bouxsein… - Endocrine …, 2019 - academic.oup.com
Bisphosphonates (BPs) are highly effective in treating osteoporosis and reducing hip,
vertebral, and other fractures by as much as 50% to 70%. However, since 2006, atypical …

Bone hydration: How we can evaluate it, what can it tell us, and is it an effective therapeutic target?

RK Surowiec, MR Allen, JM Wallace - Bone reports, 2022 - Elsevier
Water constitutes roughly a quarter of the cortical bone by volume yet can greatly influence
mechanical properties and tissue quality. There is a growing appreciation for how water can …

[HTML][HTML] Effects of novel raloxifene analogs alone or in combination with mechanical loading in the Col1a2G610c/+ murine model of osteogenesis imperfecta

R Kohler, A Creecy, DR Williams, MR Allen… - Bone, 2024 - Elsevier
Osteogenesis imperfecta (OI) is a hereditary bone disease in which gene mutations affect
collagen formation, leading to a weak, brittle bone phenotype that can cause severe skeletal …

On the evolution and contemporary roles of bone remodeling

P Kostenuik - Marcus and Feldman's osteoporosis, 2021 - Elsevier
Bone is continuously remodeled in terrestrial vertebrates and aquatic mammals throughout
life. Osteoclasts resorb mineralized bone matrix in a manner that mobilizes skeletal calcium …

Impact of single or combined drug therapy on bone regeneration in healthy and osteoporotic rats

MY Shaheen, AM Basudan, AA Niazy… - … Engineering Part A, 2021 - liebertpub.com
Complications in bone regeneration in patients with systemic impaired bone metabolism
(eg, osteoporosis) represent a rapidly increasing clinical challenge. Alendronate and …

Efficacy of combined medication of risedronate sodium and selective estrogen receptor modulator on the postmenopausal osteoporosis.

Y Deng, L Li, C Li, Y Qu - Pakistan journal of …, 2020 - search.ebscohost.com
To evaluate the efficacy of combined medication of risedronate sodium and raloxifene, a
selective estrogen receptor modulator (SERM) on the postmenopausal osteoporosis …

[PDF][PDF] The Impact of in vitro soaking with Calcitonin or Raloxifene on Mechanical Properties in Healthy and Diseased Mouse Bone

RK Surowiec, R Saldivar, RK Rai… - American Society of …, 2022 - bbml.et.iupui.edu
Raloxifene (RAL) reduces clinical fracture risk despite modest effects on bone
mass/density1. This may be due to increased hydration, which we have shown improves …

Targeting Bone Quality in Murine Models of Osteogenesis Imperfecta, Diabetes, and Chronic Kidney Disease

RK Kohler - 2024 - hammer.purdue.edu
Skeletal fragility can be caused by a wide array of diseases and disorders, but the most
difficult etiologies to clinically circumvent are those in which the body loses not just bone …

Novel Models to Image and Quantify Bone Drug Efficacy and Disease Progression In Vivo: Addressing the Fragility Phenotype

R Surowiec - 2019 - deepblue.lib.umich.edu
Bone is a composite biomaterial of mineral crystals, organic matrix, and water. Each
contributes to bone quality and strength and may change independently, or together, with …

Age-and Diabetes-Related Changes in the Matrix and Fracture Resistance of Bone

A Creecy - 2018 - ir.vanderbilt.edu
Fracture resistance of bone depends on the hierarchical organization of its constituents,
primarily the organic matrix, mineral, and water, and as such, requires characterization at …